Xiongbin Lu was named co-leader of the Experimental and Developmental Therapeutics Research Program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
